107 related articles for article (PubMed ID: 8813554)
21. The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists.
Dolezal V; Tucek S
Br J Pharmacol; 1998 Jul; 124(6):1213-8. PubMed ID: 9720793
[TBL] [Abstract][Full Text] [Related]
22. Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.
Pfaffendorf M; Batink HD; Tränkle C; Mohr K; van Zwieten PA
J Auton Pharmacol; 2000 Feb; 20(1):55-62. PubMed ID: 11048962
[TBL] [Abstract][Full Text] [Related]
23. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
Lanzafame A; Christopoulos A; Mitchelson F
J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
[TBL] [Abstract][Full Text] [Related]
24. Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.
Zahn K; Eckstein N; Tränkle C; Sadée W; Mohr K
J Pharmacol Exp Ther; 2002 May; 301(2):720-8. PubMed ID: 11961078
[TBL] [Abstract][Full Text] [Related]
25. Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.
Jakubík J; Tucek S
Br J Pharmacol; 1994 Dec; 113(4):1529-37. PubMed ID: 7889311
[TBL] [Abstract][Full Text] [Related]
26. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.
Gharagozloo P; Lazareno S; Popham A; Birdsall NJ
J Med Chem; 1999 Feb; 42(3):438-45. PubMed ID: 9986715
[TBL] [Abstract][Full Text] [Related]
27. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
[TBL] [Abstract][Full Text] [Related]
28. Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups.
Jakubík J; Tucek S
Eur J Pharmacol; 1995 Apr; 289(2):311-9. PubMed ID: 7621905
[TBL] [Abstract][Full Text] [Related]
29. Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
Jakubík J; Bacáková L; Lisá V; el-Fakahany EE; Tucek S
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8705-9. PubMed ID: 8710935
[TBL] [Abstract][Full Text] [Related]
30. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies.
Lazareno S; Gharagozloo P; Kuonen D; Popham A; Birdsall NJ
Mol Pharmacol; 1998 Mar; 53(3):573-89. PubMed ID: 9495826
[TBL] [Abstract][Full Text] [Related]
31. Two populations of binding sites for muscarinic antagonists in the rat heart.
Hulme EC; Berrie CP; Birdsall NJ; Burgen AS
Eur J Pharmacol; 1981 Jul; 73(2-3):137-42. PubMed ID: 7308290
[TBL] [Abstract][Full Text] [Related]
32. Search for lead structures to develop new allosteric modulators of muscarinic receptors.
Tränkle C; Kostenis E; Burgmer U; Mohr K
J Pharmacol Exp Ther; 1996 Nov; 279(2):926-33. PubMed ID: 8930201
[TBL] [Abstract][Full Text] [Related]
33. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
[TBL] [Abstract][Full Text] [Related]
34. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
Tränkle C; Mohr K
Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
[TBL] [Abstract][Full Text] [Related]
35. Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.
Freedman SB; Beer MS; Harley EA
Eur J Pharmacol; 1988 Oct; 156(1):133-42. PubMed ID: 3208836
[TBL] [Abstract][Full Text] [Related]
36. Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors.
Zlotos DP; Buller S; Holzgrabe U; Mohr K
Bioorg Med Chem; 2003 Jun; 11(12):2627-34. PubMed ID: 12757728
[TBL] [Abstract][Full Text] [Related]
37. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
Potter LT; Ferrendelli CA; Hanchett HE; Hollifield MA; Lorenzi MV
Mol Pharmacol; 1989 May; 35(5):652-60. PubMed ID: 2725474
[TBL] [Abstract][Full Text] [Related]
38. The allosteric binding profile of himbacine: a comparison with other cardioselective muscarinic antagonists.
Lee NH; el-Fakahany EE
Eur J Pharmacol; 1990 Apr; 179(1-2):225-9. PubMed ID: 2364985
[TBL] [Abstract][Full Text] [Related]
39. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
Hu J; Wang SZ; Forray C; el-Fakahany EE
Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
[TBL] [Abstract][Full Text] [Related]
40. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]